Second Tokushima Factory Otsuka Pharmaceutical recalls

Second Tokushima Factory Otsuka Pharmaceutical has 4 recalls on record with the FDA and USDA, the earliest in 2024 and the latest reported on 1 May 2024. 4 are still ongoing. The most frequent reason is packaging defects.

Total recalls4since 2024

Last 12 months0reported

Class I00% of total

Ongoing4latest 1 May 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 4 100%

Why second tokushima factory otsuka pharmaceutical is recalled

Packaging Defects4100%

By year

20244100%

Ongoing second tokushima factory otsuka pharmaceutical recalls

4 active

Reported	Class	Recall	Company	Reason	Where
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory Otsuka Pharmaceutical	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory Otsuka Pharmaceutical	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory Otsuka Pharmaceutical	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory Otsuka Pharmaceutical	Packaging Defects	Nationwide

All second tokushima factory otsuka pharmaceutical recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory Otsuka Pharmaceutical	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory Otsuka Pharmaceutical	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory Otsuka Pharmaceutical	Packaging Defects	Nationwide
1 May 2024Drug	CLASS III	Abilify (aripiprazole) recalled by Second Tokushima FactoryAbilify	Second Tokushima Factory Otsuka Pharmaceutical	Packaging Defects	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.